Search Results for "Sangart Pharma"

05:20 EST 29th January 2015 | BioPortfolio

Original Source: Sangart, Inc.

Sangart was founded in 1998 by Robert M. Winslow to develop and commercialize products and technologies related to targeted delivery of oxygen to tissue. Its lead product, Hemospan® , is the result of more than 15 years of peer-reviewed research, which led to breakthrough discoveries of how hemoglobin, the natural oxygen carrier inred blood cells, functions in a cell-free environment. It is well known that blood transfusion has the potential to transmit infectious disease. In addition, increasing restricti...

Matching Channels

Datamonitor - aims to help its clients operating in the pharmaceuticals, healthcare and biotechnology fields, offering world-leading products and services to meet the challenges of this rapidly evolving marketplace

The Datamonitor Group aims to help its clients operating in the pharmaceuticals, healthcare and biotechnology fields, offering world-leading products and services to meet the challenges of this rapi...


Labs are the hub of much of modern medicine, either in the hospital setting processing patients blood tests and other samples, in research institutions at many universities or in the headquarters of...


OxyContin, an narcotic analgesic produced by Purdue Pharma LP, nets $3m in sales annually, placing it 8th in the world for annual sales. OxyContin in the brand name for oxycodone, and is similar t...


Eligard® is a hormone compound for the treatment of advanced, hormone-dependent prostate cancer. The active ingredient (leuprolide acetate) significantly reduces the level of the male sex hormon...

Devices - medical, biotech, pharma

A medical device is a product which is used for medical purposes in patients, in diagnosis, therapy or surgery.  Medical devices act by physical, mechanical, thermal, physico-chemical or chemic...

Matching News

Biotech Equities Roundup -- Keryx Biopharma, Vertex Pharma, NPS Pharma, Cubist Pharma, and Idera Pharma

LONDON, August 6, 2014 /PRNewswire/ --read more

VERONA PHARMA PLC - CMO appointment & incorporation of Verona Pharma Inc

Verona Pharma plc ("Verona Pharma" or the "Company") Appointment of Dr Kenneth Newman as Chief Medical Officer and Incorporation of Verona Pharma, Inc. 17 December 2014, Cardiff - Verona Pharma pl...

Pharma Stocks under Review -- Impax Laboratories, Sanofi, GW Pharma, AcelRx Pharma, and Salix Pharma

LONDON, July 23, 2014 /PRNewswire/ -- On Tuesday, July 22, 2014, the NASDAQ Composite ended at 4,456.02, up 0.71%, the Dow Jones Industrial Average finished the day 0.36% higher at 17,113.54, and ...

Technical Analysis on Pharma Equities -- Mylan, AVANIR Pharma, Horizon Pharma, VIVUS, and Auxilium Pharma

LONDON, August 6, 2014 /PRNewswire/ -- On Tuesday, August 5, 2014, the NASDAQ Composite ended at 4,352.84, down 0.71%, the Dow Jones Industrial Average declined 0.84%, to finish the day at 16,429....

Omega Pharma rumored to be sought after by big pharma companies

Belgium-based healthcare company Omega Pharma NV is allegedly attracting numerous bids from businesses across the big pharma companies, according to Bloomberg Businessweek. Perrigo and Boehringer Inge...

Expert Briefing on Biotech Stocks -- Nanosphere, Vanda Pharma, Synta Pharma, Halozyme Therapeutics, and Isis Pharma

LONDON, August 14, 2014 /PRNewswire/ --read more

Cocrystal Pharma and RFS Pharma Merge to Create Antiviral Development Organization

Cocrystal Pharma, a biotechnology company developing novel antiviral therapeutics for human diseases, today announced the closing of its merger with RFS Pharma, LLC, a privately owned biotech company ...

Technical Data on Biotech Equities -- Aegerion Pharma, ACADIA Pharma, Inovio Pharma, Curis, and Seattle Genetics

LONDON, August 20, 2014 /PRNewswire/ --read more

Matching PubMed Articles

Search Whole site using Google

Search BioPortfolio:
Advertisement Advertisement